RPL30P10

Across TCGA pan-cancer cohorts, RPL30P10 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPL30P10 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL30P10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL30P10 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

KIRC, ACC, and HNSC are the cancer types where RPL30P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.161	0.649	<.001	138	view →
ACC	OS	Tertile	All	0.145	0.888	<.001	117	view →
HNSC	DFS	Tertile	All	0.688	0.308	.006	87	view →
STAD	OS	Quartile	II,III,IV	0.333	0.658	<.001	72	view →
UCEC	OS	Tertile	IV	0.133	0.754	<.001	72	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.007	36	view →
UCS	DFS	Tertile	II,III,IV	0.130	0.476	.014	36	view →
SARC	OS	Tertile	All	0.197	0.772	<.001	21	view →
LUSC	DFS	Tertile	All	0.615	0.804	.039	21	view →
LUAD	DFS	Tertile	All	0.920	0.634	.027	21	view →
TGCT	OS	Tertile	All	0.847	0.968	.039	18	view →
PRAD	DFS	Tertile	All	0.564	0.794	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPL30P10–KIRC (DFS)

Open the KIRC breakdown →